These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24117320)

  • 1. Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37.
    Xhindoli D; Pacor S; Guida F; Antcheva N; Tossi A
    Biochem J; 2014 Jan; 457(2):263-75. PubMed ID: 24117320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New aspects of the structure and mode of action of the human cathelicidin LL-37 revealed by the intrinsic probe p-cyanophenylalanine.
    Xhindoli D; Morgera F; Zinth U; Rizzo R; Pacor S; Tossi A
    Biochem J; 2015 Feb; 465(3):443-57. PubMed ID: 25378136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primate cathelicidin orthologues display different structures and membrane interactions.
    Morgera F; Vaccari L; Antcheva N; Scaini D; Pacor S; Tossi A
    Biochem J; 2009 Feb; 417(3):727-35. PubMed ID: 18922132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RL-37, an alpha-helical antimicrobial peptide of the rhesus monkey.
    Zhao C; Nguyen T; Boo LM; Hong T; Espiritu C; Orlov D; Wang W; Waring A; Lehrer RI
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2695-702. PubMed ID: 11557457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
    Wang G; Mishra B; Epand RF; Epand RM
    Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-Terminal VPRTES Tail of LL-37 Influences the Mode of Attachment to a Lipid Bilayer and Antimicrobial Activity.
    de Miguel Catalina A; Forbrig E; Kozuch J; Nehls C; Paulowski L; Gutsmann T; Hildebrandt P; Mroginski MA
    Biochemistry; 2019 May; 58(19):2447-2462. PubMed ID: 31016971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics.
    Wang Y; Hong J; Liu X; Yang H; Liu R; Wu J; Wang A; Lin D; Lai R
    PLoS One; 2008 Sep; 3(9):e3217. PubMed ID: 18795096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.
    Wang G
    J Biol Chem; 2008 Nov; 283(47):32637-43. PubMed ID: 18818205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.
    Oren Z; Lerman JC; Gudmundsson GH; Agerberth B; Shai Y
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):501-13. PubMed ID: 10417311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human antimicrobial peptides: defensins, cathelicidins and histatins.
    De Smet K; Contreras R
    Biotechnol Lett; 2005 Sep; 27(18):1337-47. PubMed ID: 16215847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural remodeling and oligomerization of human cathelicidin on membranes suggest fibril-like structures as active species.
    Sancho-Vaello E; François P; Bonetti EJ; Lilie H; Finger S; Gil-Ortiz F; Gil-Carton D; Zeth K
    Sci Rep; 2017 Nov; 7(1):15371. PubMed ID: 29133814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human cathelicidin LL-37--A pore-forming antibacterial peptide and host-cell modulator.
    Xhindoli D; Pacor S; Benincasa M; Scocchi M; Gennaro R; Tossi A
    Biochim Biophys Acta; 2016 Mar; 1858(3):546-66. PubMed ID: 26556394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37.
    Sigurdardottir T; Andersson P; Davoudi M; Malmsten M; Schmidtchen A; Bodelsson M
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2983-9. PubMed ID: 16940092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathelicidins from the bullfrog Rana catesbeiana provides novel template for peptide antibiotic design.
    Ling G; Gao J; Zhang S; Xie Z; Wei L; Yu H; Wang Y
    PLoS One; 2014; 9(3):e93216. PubMed ID: 24675879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure dependence of biological activities for primate cathelicidins.
    Tomasinsig L; Morgera F; Antcheva N; Pacor S; Skerlavaj B; Zanetti M; Tossi A
    J Pept Sci; 2009 Sep; 15(9):576-82. PubMed ID: 19472166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.
    Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Tanaka S; Heumann D
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):972-82. PubMed ID: 12204946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37.
    Ciornei CD; Sigurdardóttir T; Schmidtchen A; Bodelsson M
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2845-50. PubMed ID: 15980359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cathelicidins in the innate host defenses of mammals.
    Zanetti M
    Curr Issues Mol Biol; 2005 Jul; 7(2):179-96. PubMed ID: 16053249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37.
    Wang G; Epand RF; Mishra B; Lushnikova T; Thomas VC; Bayles KW; Epand RM
    Antimicrob Agents Chemother; 2012 Feb; 56(2):845-56. PubMed ID: 22083479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions.
    Nagaoka I; Kuwahara-Arai K; Tamura H; Hiramatsu K; Hirata M
    Inflamm Res; 2005 Feb; 54(2):66-73. PubMed ID: 15750713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.